Survival in Young Patients (Less than 40 Years) with Follicular Lymphoma: A population Based Study by the Scotland and Newcastle Lymphoma Group

Reference

• Portlock, CS. and Rosenberg, S.A. (1979) "No initial therapy for Stage III and IV non Hodgkin's lymphoma of favourable histologic types", Annals of Internal Medicine, 90, 10–13.
   Google Scholar
• Horning, Si. and Rosenberg, S.A. (1984) "The natural history of initially untreated low-grade non-Hodgkin's lymphomas", New England Journal of Medicine, 311, 1471 — 1475.
   Google Scholar
• Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., et al. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood, 84, 1361–1392.
   Google Scholar
• Non-Hodgkin's Lymphoma Classification Project (1997) "A clinical evaluation of the International Lymphoma Study Group classifica-tion of non-Hodgkin's lymphoma", Blood, 89, 3909— 3918.
   Google Scholar
• Harris, N.L., Jaffe, ES., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., et al. (1999) "World Health Organization classification of neoplastic diseases of the hemato-poietic and lymphoid tissues: report of the Clinical Advisory Committee meeting — Airlie House, Virginia, November 1997", Journal of Clinical Oncology, 17, 3835 — 3849.
   Google Scholar
• Glass, A., Karnell, L. and Menck, H. (1997) "The National Cancer Data Base report on non-Hodgkin's lymphoma", Cancer, 80, 2311 — 2320.
   Google Scholar
• Armitage, J.0. and Weisenburger, D.D. (1998) "New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classifica-tion Project", Journal of Clinical Oncology, 16, 2780–2795.
   Google Scholar
• Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) "National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage", Cancer, 49, 2112 — 2135.
   Google Scholar
• Anderson, T., Chabner, B.A., Young, R.C., Berard, C.W., Garvin, A.J., Simo, R.M., et al. (1982) "Malignant lymphomas: The histology and staging of 473 patients at the National Cancer Institute", Cancer, 50, 2699–2707.
   Google Scholar
• Gallagher, C.J., Gregory, W.M., Jones, A.E., Stansfeld, A.G., Richards, M.A., Dhaliwal, H.S., et al. (1986) "Follicular lympho-ma: prognostic factors for response and survival", Journal of Clinical Oncology, 4, 1470–1480.
   PubMed Web of Science ®Google Scholar
• Longo, D.L. (1993) "What's the deal with follicular lymphomas?", Journal of Clinical Oncology, 11, 202–208.
   PubMed Web of Science ®Google Scholar
• Johnson, P.W., Rohatiner, A.Z., Whelan, J.S., Price, C.G., Love, S., Lim, J., et al. (1995) "Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center", Journal of Clinical Oncology, 13, 140— 147.
   PubMed Web of Science ®Google Scholar
• Johnson, R.E., Canellos, G.P., Young, R.C., Chabner, B.A. and DeVita, V.T. (1978) "Chemotherapy (cyclophosphamide, vincristine and prednisone) versus radiotherapy (TBI) for stage III-IV poorly differentiated lymphocytic lymphoma", Cancer Treatment Reports, 62, 321 — 325.
   Google Scholar
• Jones, Si., Grozea, P.N., Miller, T.P., Van Slyck, E.J., Balcerzak, S.P., Costanzi, ii., et al. (1985) "Chemotherapy with cyclopho-sphamide, doxorubicin, vincristine and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study", Journal of Clinical Oncology, 3, 1318 —1324.
   PubMed Web of Science ®Google Scholar
• Chen, M.G., Prosnitz, L.R., Gonzalez-Serva, A. and Fischer, D.B. (1979) "Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma", Cancer, 43, 1245 — 1254.
   Google Scholar
• McLaughlin, P., Fuller, L.M., Velasquez, W.S., Sullivan-Halley, J.A., Butler, ii. and Cabanillas, F. (1986) "Stage I-II follicular lymphoma. Treatment results for 76 patients", Cancer, 58, 1596 — 1602.
   Google Scholar
• MacManus, M. and Hoppe, R.T. (1996) "Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University", Journal of Clinical Oncology, 14, 1282— 1290.
   Google Scholar
• Schouten, H.C., Bierman, P.J., Vaughan, W.P., Kessinger, A., Vose, J.M., Weisenburger, D.D., et al. (1989) "Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation", Blood, 74, 2579 — 2584.
   Google Scholar
• Fouillard, L., Gorin, N.C., Laporte, J.P., Douay, L., Lopez, M., Isnard, F., et al. (1991) "Feasibility of autologous bone marrow transplantation for early consolidation of follicular non-Hodgkin's lymphoma", European Journal of Haematology, 46, 279–284.
   Google Scholar
• Freedman, AS., Ritz, J., Neuberg, D., Anderson, K.C., Rabinaowe, S.N., Mauch, P., et al. (1991) "Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma", Blood, 77, 2524 — 2529.
   Google Scholar
• Colombat, P., Donadio, D., Fouillard, L., Milpied, N., Tilly, H., Pico, J., et al. (1994) "Value of autologous bone marrow transplantation in follicular lymphoma: A France Autogreffe retrospective study of 42 patients", Bone Marrow Transplant, 13, 157— 162.
   PubMed Web of Science ®Google Scholar
• Rohatiner, A.Z., Johnson, P.W., Price, C.G., Arnott, Si., Amess, J.A., Norton, A.J., et al. (1994) "Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma", Journal of Clinical Oncology, 12, 1177 — 1184.
   Google Scholar
• Freedman, AS., Neuberg, D., Mauch, P., Soiffer, R.J., Anderson, K.C., Fisher, D.C., et al. (1999) "Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma", Blood, 94, 3325–3333.
   Google Scholar
• Horning, S., Negrin, R.S., Hoppe, R.T., Rosenberg, S.A., Chao, N.J., Long, G.D., et al. (2001) "High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial", Blood, 97, 404–409.
   Google Scholar
• Hunault-Berger, M., Ifrah, N. and Solal-Celigny, P. (2002) "Intensive therapies in follicular non-Hodgkin's lymphomas", Blood, 100, 1141–1152.
   Google Scholar
• Schouten, H.C., Qian, W., Kvaloy, S., Porcellini, A., Hagberg, H., Johnson, H.E., et al. (2003) "High-dose therapy improves progres-sion free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomised European CUP trial", Journal of Clinical Oncology, 21, 3918— 3927.
   PubMed Web of Science ®Google Scholar
• van Besien, K.W., Khouri, IF., Giralt, S.A., McCarthy, P., Mehra, R., Andersson, B.S., et al. (1995) "Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management", Journal of Clinical Oncology, 13, 1096–1102.
   PubMed Web of Science ®Google Scholar
• van Besien, K., Sobocinski, K.A., Rowlings, P.A., Murphy, S.C., Armitage, J.0., Bishop, M.R., et al. (1998) "Allogeneic bone marrow transplantation for low-grade lymphoma", Blood, 92, 1832— 1836.
   Google Scholar
• Juckett, M., Rowlings, P., Hessner, M., Keever-Taylor, C., Burns, W., Camitta, B., et al. (1998) "T-cell depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up", Bone Marrow Transplant, 21, 893— 899.
   Google Scholar
• Soiffer, R.J., Freedman, AS., Neuberg, D., Fisher, D.C., Alyea, E.P., Gribben, J., et al. (1998) "T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma", Bone Marrow Transplant, 21, 1177–1181.
   PubMed Web of Science ®Google Scholar
• Khouri, IF., Keating, M., Korbling, M., Przepiorka, D., Anderlini, P., O'Brien, S., et al. (1998) "Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemo-therapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies", Journal of Clinical Oncology, 16, 2817–2824.
   PubMed Web of Science ®Google Scholar
• van Besien, K., Loberiza, FR., Bajorunaite, R., Armitage, J.0., Bashey, A., Burns, L.J., et al. (2003) "Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma", Blood, 102, 3251–3259.
   Google Scholar
• Romaguera, J.E., McLaughlin, P., North, L., Dixon, D., Silver-mintz, K.B., Garnsey, L.A., et al. (1991) "Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: A risk model", Journal of Clinical Oncology, 9, 762–769.
   PubMed Web of Science ®Google Scholar
• Lopez-Guillermo, A., Montserrat, E., Bosch, F., Terol, M.J., Campo, E. and Rozman, C. (1994) "Applicability of the Interna-tional Index for aggressive lymphomas to patients with low-grade lymphoma", Journal of Clinical Oncology, 12, 1343–1348.
   Google Scholar
• Decaudin, D., Lepage, E., Brousse, N., Brice, P., Harousseau, J.L., Belhadj, K., et al. (1999) "Low grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients — a study of the Groupe d'Etudes des Lymphomes de l'Adulte", Journal of Clinical Oncology, 17, 2499 — 2505.
   Google Scholar
• Federico, M., Vitolo, U., Zinzani, P.L., Chisesi, T., Clo, V., Bellesi, G., et al. (2000) "Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi", Blood, 95, 783–789.
   PubMed Web of Science ®Google Scholar
• Leonard, R.C.F., Hayward, R.L., Prescott, R.J. and Wang, J.-X. (1991) "The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma", Annals of Oncology, 2, 655–663.
   PubMed Web of Science ®Google Scholar
• Cameron, D.A., Leonard, R.C., Mao, J.H. and Prescott, R.J. (1993) "Identification of prognostic groups in follicular lymphoma. The Scotland and Newcastle Lymphoma Group Therapy Working Party", Leukemia and Lymphoma, 10, 89— 99.
   PubMed Web of Science ®Google Scholar
• International Non-Hodgkin's Lymphoma Prognostic Factors Pro-ject (1993). "A predictive model for aggressive non-Hodgkin's lymphoma", New England Journal of Medicine, 329, 987–994.
   Google Scholar
• Mann, R.B. and Berard, C.W. (1983) "Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method", Hematologic Oncology, 1, 187–192.
   PubMedGoogle Scholar
• Kaplan, E.L. and Meier, P. (1958) "Non-parametric estimation from incomplete observations", Journal of the American Statistical Association, 53, 457 — 481.
   Web of Science ®Google Scholar
• Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, D.R., Howard, S..V., et al. (1977) "Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples", British Journal of Cancer, 35, 1–39.
   PubMed Web of Science ®Google Scholar
• Hoppe, R., Kushlan, P., Kaplan, H.S., Rosenberg, S.A. and Brown, B.W. (1981) "The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: A preliminary report of a randomized trial comparing single agent chemotherapy, and whole body irradiation", Blood, 58, 592— 598.
   Google Scholar
• Taylor, P.R.A., Jackson, G.H., Galloway, M.J., Soukop, M., Tinegate, H., Angus, B., et al. (2000) "Primary treatment of low grade non-Hodgkin's lymphoma using an all oral anthracycline containing regimen, chlorambucil, idarubicin, dexamethasone (CID) — a phase II study", Cancer Chemotherapy and Pharmacology, 36, 63–68.
   Google Scholar
• Fisher, RI., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., et al. (1993) "A comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma", New England Journal of Medicine, 328, 1002 — 1006.
   Google Scholar
• McElwain, T.J., Toy, J., Smith, E., Peckham, M.J. and Austin, D.E. (1977) "Combination chemotherapy of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease", British Journal of Cancer, 36, 276–280.
   Google Scholar
• Radford, J.A. and Crowther, D. (1991) "Treatment of relapsed Hodgkin's disease using a weekly chemotherapy of short duration: results of a pilot study in 20 patients", Annals of Oncology, 2, 505 — 509.
   PubMed Web of Science ®Google Scholar
• Atra, A., Meller, S.T., Stevens, R.S., Hobson, R., Grundy, R. and Carter, R.L. (1998) "Conservative management of follicular non-Hodgkin's lymphoma", British Journal of Haematology, 103, 220 — 223.
   PubMed Web of Science ®Google Scholar
• O'Brien, M.E., Easterbrook, P., Powell, J., Blackledge, G.R., Jones, L., MacLennan, IC., et al. (1991) "The natural history of low grade non-Hodgkin's lymphoma and the impact of a no initial treatment policy on survival", Quarterly Journal of Medicine, 80, 651— 660.
   Google Scholar
• Miller, T.P., LeBlanc, M., Grogan, T.M. and Fisher, RI. (1997) "Follicular lymphomas: do histologic subtypes predict outcome?", Hematology and Oncology Clinics of North America, 11, 893–900.
   PubMed Web of Science ®Google Scholar
• Marcus, R., Imrie, K., Belch, A., Cunningham, D., Flores, E., Catalano, J., et al. (2003) "An international multi-centre, rando-mized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkin's lymphoma", Blood, 102, ASH Annual Meeting, San Diego, Abstract 87.
   Google Scholar